{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:03:37Z","timestamp":1790863417439,"version":"4.1.0"},"reference-count":299,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015550","name":"Ministry of Health","doi-asserted-by":"publisher","award":["RC 2025"],"award-info":[{"award-number":["RC 2025"]}],"id":[{"id":"10.13039\/501100015550","id-type":"DOI","asserted-by":"publisher"}]},{"award":["RC 2025"],"award-info":[{"award-number":["RC 2025"]}],"id":[{"id":"https:\/\/ror.org\/00789fa95","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Cardio-oncology explores the complex interplay between cancer biology and cardiovascular health, particularly the cardiotoxic effects of cancer therapies. Both microRNAs (miRNAs) and alarmins have emerged as key molecular mediators linking tumor progression and cardiac stress, representing promising biomarkers and therapeutic targets. In skin and breast cancer, specific miRNAs, including miR-21, miR-155, miR-34a, and the miR-200 family, regulate tumor proliferation, invasion, metastasis, and therapy resistance. Alarmins such as NPM, HMGB1, HSPs, IL-33, and S100 proteins modulate inflammatory signaling, oxidative stress, and tissue remodeling, contributing to both tumor progression and cardiomyocyte dysfunction. These molecules are also implicated in chemotherapy- and targeted therapy-induced cardiotoxicity, including apoptosis, fibrosis, and impaired cardiac function. This review highlights the dual role of miRNAs and alarmins in tumor biology and cardiovascular toxicity, emphasizing their potential as circulating biomarkers for early detection and monitoring. Therapeutic strategies targeting this axis\u2014including miRNA mimics\/inhibitors and alarmin modulators\u2014may provide synergistic benefits by reducing cardiotoxicity while suppressing tumor growth. Understanding miRNA\u2013alarmin relationships, including direct interactions such as the NPM\/miR-200c axis, as well as their broader regulatory networks in cardio-oncology, offers novel avenues for precision medicine, enabling integrated approaches to monitor, prevent, and treat therapy-related cardiac complications in patients with skin and breast cancers.<\/jats:p>","DOI":"10.3390\/ijms27188329","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:18:26Z","timestamp":1790860706000},"page":"8329","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MicroRNAs and Alarmins in Cardio-Oncology: Biomarkers and Therapeutic Implications in Skin and Breast Cancer"],"prefix":"10.3390","volume":"27","author":[{"given":"Federica","family":"Cannistr\u00e0","sequence":"first","affiliation":[{"name":"Institute of Translational Pharmacology (IFT), National Research Council of Italy (CNR), 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Sileno","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Regenerative Medicine, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2850-1124","authenticated-orcid":false,"given":"Francesco","family":"Cribari","sequence":"additional","affiliation":[{"name":"Unit of Cardiology, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7682-6357","authenticated-orcid":false,"given":"Marco","family":"D\u2019Agostino","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Regenerative Medicine, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Martino","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Anaesthesiology and Cardiovascular Sciences, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Morrone","sequence":"additional","affiliation":[{"name":"Complex Operating Unit of Paediatrics and Neonatal Care, Spoke Hospital of Corigliano-Rossano, 87064 Cosenza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2379-9471","authenticated-orcid":false,"given":"Guido","family":"Melillo","sequence":"additional","affiliation":[{"name":"Unit of Cardiology, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8606-9628","authenticated-orcid":false,"given":"Federica","family":"Limana","sequence":"additional","affiliation":[{"name":"Dipartimento di Promozione delle Scienze Umane e della Qualit\u00e0 della Vita, San Raffaele University of Rome, 00166 Rome, Italy"},{"name":"Laboratorio di Patologia Cellulare e Molecolare, IRCCS San Raffaele Roma, 00166 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9054-337X","authenticated-orcid":false,"given":"Alessandra","family":"Magenta","sequence":"additional","affiliation":[{"name":"Institute of Translational Pharmacology (IFT), National Research Council of Italy (CNR), 00133 Rome, Italy"},{"name":"Laboratory of Molecular Regenerative Medicine, Istituto Dermopatico dell\u2019Immacolata, IDI-IRCCS, 00167 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","article-title":"Defining Cardiovascular Toxicities of Cancer Therapies: An International Cardio-Oncology Society (IC-OS) Consensus Statement","volume":"43","author":"Herrmann","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on Cardio-Oncology Developed in Collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1093\/eurheartj\/ehae637","article-title":"Breast Cancer and Cardiovascular Health","volume":"45","author":"Marco","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s11864-021-00924-2","article-title":"Cardiotoxicity of Systemic Melanoma Treatments","volume":"23","author":"Mukunda","year":"2022","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_5","first-page":"e1","article-title":"Cardiac Biomarkers in the Field of Cardio-Oncology","volume":"11","author":"Cardinale","year":"2022","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ncrna.2025.05.002","article-title":"The Emerging Role of MiRNAs in Biological Aging and Age-Related Diseases","volume":"13","author":"Turko","year":"2025","journal-title":"Non-Coding RNA Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ilieva, M., Panella, R., and Uchida, S. (2022). MicroRNAs in Cancer and Cardiovascular Disease. Cells, 11.","DOI":"10.3390\/cells11223551"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"V\u00e9n\u00e9reau, E., Ceriotti, C., and Bianchi, M.E. (2015). DAMPs from Cell Death to New Life. Front. Immunol., 6.","DOI":"10.3389\/fimmu.2015.00422"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Beji, S., D\u2019Agostino, M., Gambini, E., Sileno, S., Scopece, A., Vinci, M.C., Milano, G., Melillo, G., Napolitano, M., and Pompilio, G. (2021). Doxorubicin Induces an Alarmin-like TLR4-Dependent Autocrine\/Paracrine Action of Nucleophosmin in Human Cardiac Mesenchymal Progenitor Cells. BMC Biol., 19.","DOI":"10.1186\/s12915-021-01058-5"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/CIRCULATIONAHA.118.039262","article-title":"S100a8\/A9 Signaling Causes Mitochondrial Dysfunction and Cardiomyocyte Death in Response to Ischemic\/Reperfusion Injury","volume":"140","author":"Li","year":"2019","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/eurheartj\/ehz461","article-title":"Inhibition of Pro-Inflammatory Myeloid Cell Responses by Short-Term S100A9 Blockade Improves Cardiac Function after Myocardial Infarction","volume":"40","author":"Yndigegn","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101613","DOI":"10.1016\/j.esmoop.2023.101613","article-title":"Incidence of Interstitial Lung Disease and Cardiotoxicity with Trastuzumab Deruxtecan in Breast Cancer Patients: A Systematic Review and Single-Arm Meta-Analysis","volume":"8","author":"Soares","year":"2023","journal-title":"ESMO Open"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1200\/JCO.1998.16.10.3426","article-title":"Capillary Protein Leak Syndrome Appears to Explain Fluid Retention in Cancer Patients Who Receive Docetaxel Treatment","volume":"16","author":"Semb","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1002\/cncr.34928","article-title":"Incidence, Risk Factors, and Management of Alpelisib-associated Hyperglycemia in Metastatic Breast Cancer","volume":"129","author":"Shen","year":"2023","journal-title":"Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/bcp.15006","article-title":"Concentration-QT Modelling Shows No Evidence of Clinically Significant QT Interval Prolongation with Capivasertib at Expected Therapeutic Concentrations","volume":"88","author":"Voronova","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa2109970","article-title":"Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma","volume":"386","author":"Tawbi","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e5946","DOI":"10.1097\/MD.0000000000005946","article-title":"The Cardiotoxicity of Cetuximab as Single Therapy in Chinese Chemotherapy-Refractory Metastatic Colorectal Cancer Patients","volume":"96","author":"Tang","year":"2017","journal-title":"Medicine"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/FJC.0b013e3182793ac9","article-title":"Daily Dosing of Vismodegib to Steady State Does Not Prolong the Qtc Interval in Healthy Volunteers","volume":"61","author":"Graham","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/ejhf.3753","article-title":"Prevention of Cancer Therapy-Related Cardiac Dysfunction and Heart Failure in Cancer Patients and Survivors. A Clinical Consensus Statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council","volume":"27","author":"Rakisheva","year":"2025","journal-title":"Eur. J. Heart Fail."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"pkae078","DOI":"10.1093\/jncics\/pkae078","article-title":"QTc Prolongation across CDK4\/6 Inhibitors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"8","author":"Murad","year":"2024","journal-title":"JNCI Cancer Spectr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"101154","DOI":"10.1016\/j.esmoop.2023.101154","article-title":"Major Adverse Cardiac Events and Cardiovascular Toxicity with PARP Inhibitors-Based Therapy for Solid Tumors: A Systematic Review and Safety Meta-Analysis","volume":"8","author":"Palazzo","year":"2023","journal-title":"ESMO Open"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e198890","DOI":"10.1001\/jamanetworkopen.2019.8890","article-title":"Cardiovascular Adverse Events Associated with BRAF and MEK Inhibitors","volume":"2","author":"Mincu","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jamaoncol.2024.3065","article-title":"Immune Checkpoint Inhibitor\u2013Induced Cardiotoxicity","volume":"10","author":"Nielsen","year":"2024","journal-title":"JAMA Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","article-title":"Metazoan MicroRNAs","volume":"173","author":"Bartel","year":"2018","journal-title":"Cell"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","article-title":"Regulation of MicroRNA Function in Animals","volume":"20","author":"Gebert","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Matsuyama, H., and Suzuki, H.I. (2019). Systems and Synthetic MicroRNA Biology: From Biogenesis to Disease Pathogenesis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21010132"},{"key":"ref_28","first-page":"189","article-title":"MicroRNAs: Biogenesis, Function and Applications","volume":"11","author":"Chua","year":"2009","journal-title":"Curr. Opin. Mol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of MicroRNA Biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","article-title":"Processing of Primary MicroRNAs by the Microprocessor Complex","volume":"432","author":"Denli","year":"2004","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature14281","article-title":"N6-Methyladenosine Marks Primary MicroRNAs for Processing","volume":"519","author":"Lee","year":"2015","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1101\/gad.1262504","article-title":"The Drosha-DGCR8 Complex in Primary MicroRNA Processing","volume":"18","author":"Han","year":"2004","journal-title":"Genes Dev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cell.2004.06.017","article-title":"Single Processing Center Models for Human Dicer and Bacterial RNase III","volume":"118","author":"Zhang","year":"2004","journal-title":"Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nsmb.1733","article-title":"ATP-Dependent Human RISC Assembly Pathways","volume":"17","author":"Yoda","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05983","article-title":"Intronic MicroRNA Precursors That Bypass Drosha Processing","volume":"448","author":"Ruby","year":"2007","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.cell.2013.11.027","article-title":"Mammalian 5\u2032-Capped MicroRNA Precursors That Generate a Single MicroRNA","volume":"155","author":"Xie","year":"2013","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"15163","DOI":"10.1073\/pnas.1006432107","article-title":"Conserved Vertebrate Mir-451 Provides a Platform for Dicer-Independent, Ago2-Mediated MicroRNA Biogenesis","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e3020","DOI":"10.1038\/cddis.2017.409","article-title":"Doxorubicin Upregulates CXCR4 via MiR-200c\/ZEB1-Dependent Mechanism in Human Cardiac Mesenchymal Progenitor Cells","volume":"8","author":"Beji","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1512326","DOI":"10.1155\/2019\/1512326","article-title":"MiR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in Mice","volume":"2019","author":"Hu","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.taap.2014.10.006","article-title":"Early Biomarkers of Doxorubicin-Induced Heart Injury in a Mouse Model","volume":"281","author":"Desai","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3233\/CBM-181301","article-title":"Correlation of Circulating Pro-Angiogenic MiRNAs with Cardiotoxicity Induced by Epirubicin\/Cyclophosphamide Followed by Docetaxel in Patients with Breast Cancer","volume":"23","author":"Qin","year":"2018","journal-title":"Cancer Biomark."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.etap.2011.12.023","article-title":"Let-7 g Is Involved in Doxorubicin Induced Myocardial Injury","volume":"33","author":"Fu","year":"2012","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"11879","DOI":"10.1038\/s41598-017-12192-y","article-title":"Activation of MiR-34a-5p\/Sirt1\/P66shc Pathway Contributes to Doxorubicin-Induced Cardiotoxicity","volume":"7","author":"Zhu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41419-020-02778-2","article-title":"Immune Checkpoint Inhibitor Induces Cardiac Injury through Polarizing Macrophages via Modulating MicroRNA-34a\/Kruppel-like Factor 4 Signaling","volume":"11","author":"Xia","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1080\/15384101.2019.1673618","article-title":"MiR-34b\/c Regulates Doxorubicin-Induced Myocardial Cell Injury through ITCH","volume":"18","author":"Zhang","year":"2019","journal-title":"Cell Cycle"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e004653","DOI":"10.1161\/JAHA.116.004653","article-title":"Circulating MicroRNAs: Potential Markers of Cardiotoxicity in Children and Young Adults Treated with Anthracycline Chemotherapy","volume":"6","author":"Leger","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1159\/000491896","article-title":"MicroRNA-29b Regulates the Mitochondria-Dependent Apoptotic Pathway by Targeting Bax in Doxorubicin Cardiotoxicity","volume":"48","author":"Jing","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jacbts.2018.10.006","article-title":"MiR-29b Mediates the Chronic Inflammatory Response in Radiotherapy-Induced Vascular Disease","volume":"4","author":"Eken","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e1754","DOI":"10.1038\/cddis.2015.89","article-title":"Myocardial MiR-30 Downregulation Triggered by Doxorubicin Drives Alterations in \u03b2-Adrenergic Signaling and Enhances Apoptosis","volume":"6","author":"Castellano","year":"2015","journal-title":"Cell Death Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.redox.2018.02.026","article-title":"Protective Effect of Dioscin against Doxorubicin-Induced Cardiotoxicity via Adjusting MicroRNA-140-5p-Mediated Myocardial Oxidative Stress","volume":"16","author":"Zhao","year":"2018","journal-title":"Redox Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/cbdd.14104","article-title":"Upregulation of MiR-144-3p Alleviates Doxorubicin-Induced Heart Failure and Cardiomyocytes Apoptosis via SOCS2\/PI3K\/AKT Axis","volume":"101","author":"Zhang","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41419-019-1901-x","article-title":"MiR-146a Attenuates Apoptosis and Modulates Autophagy by Targeting TAF9b\/P53 Pathway in Doxorubicin-Induced Cardiotoxicity","volume":"10","author":"Pan","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/cvr\/cvq148","article-title":"Acute Doxorubicin Cardiotoxicity Is Associated with MiR-146a-Induced Inhibition of the Neuregulin-ErbB Pathway","volume":"87","author":"Horie","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"14511","DOI":"10.3390\/ijms160714511","article-title":"MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2","volume":"16","author":"Tong","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Simone, N.L., Soule, B.P., Ly, D., Saleh, A.D., Savage, J.E., Degraff, W., Cook, J., Harris, C.C., Gius, D., and Mitchell, J.B. (2009). Ionizing Radiation-Induced Oxidative Stress Alters MiRNA Expression. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006377"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"6994","DOI":"10.18632\/oncotarget.14355","article-title":"Circulating MiR-1 as a Potential Biomarker of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients","volume":"8","author":"Rigaud","year":"2017","journal-title":"Oncotarget"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/jat.3185","article-title":"Circulating Mir-208a Fails as a Biomarker of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients","volume":"35","author":"Ferreira","year":"2015","journal-title":"J. Appl. Toxicol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4149\/gpb_2015038","article-title":"Myocardial Connexin-43 and PKC Signalling Are Involved in Adaptation of the Heart to Irradiation-Induced Injury: Implication of MiR-1 and MiR-21","volume":"35","author":"Viczenczova","year":"2016","journal-title":"Gen. Physiol. Biophys."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12012-022-09748-4","article-title":"MicroRNA MiR-133a as a Biomarker for Doxorubicin-Induced Cardiotoxicity in Women with Breast Cancer: A Signaling Pathway Investigation","volume":"22","author":"Alves","year":"2022","journal-title":"Cardiovasc. Toxicol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"597032","DOI":"10.1155\/2015\/597032","article-title":"MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction","volume":"2015","author":"Tony","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Vacchi-Suzzi, C., Bauer, Y., Berridge, B.R., Bongiovanni, S., Gerrish, K., Hamadeh, H.K., Letzkus, M., Lyon, J., Moggs, J., and Paules, R.S. (2012). Perturbation of MicroRNAs in Rat Heart during Chronic Doxorubicin Treatment. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0040395"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"7954","DOI":"10.1038\/s41598-021-87209-8","article-title":"Detecting Early Onset of Anthracyclines-Induced Cardiotoxicity Using a Novel Panel of Biomarkers in West-Virginian Population with Breast Cancer","volume":"11","author":"Lakhani","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Wan, Q., Xu, T., Ding, W., Zhang, X., Ji, X., Yu, T., Yu, W., Lin, Z., and Wang, J. (2018). MiR-499-5p Attenuates Mitochondrial Fission and Cell Apoptosis via P21 in Doxorubicin Cardiotoxicity. Front. Genet., 9.","DOI":"10.3389\/fgene.2018.00734"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"12325","DOI":"10.1002\/jev2.12325","article-title":"The MiR-126-5p and MiR-212-3p in the Extracellular Vesicles Activate Monocytes in the Early Stage of Radiation-induced Vascular Inflammation Implicated in Atherosclerosis","volume":"12","author":"Choi","year":"2023","journal-title":"J. Extracell. Vesicles"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41419-018-0797-1","article-title":"Downregulation of MiR-130a, Antagonized Doxorubicin-Induced Cardiotoxicity via Increasing the PPAR\u03b3 Expression in MESCs-Derived Cardiac Cells","volume":"9","author":"Pakravan","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/embor.2010.117","article-title":"The ZEB\/MiR-200 Feedback Loop\u2014A Motor of Cellular Plasticity in Development and Cancer?","volume":"11","author":"Brabletz","year":"2010","journal-title":"EMBO Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/CIRCRESAHA.116.310274","article-title":"The Emerging Role of MiR-200 Family in Cardiovascular Diseases","volume":"120","author":"Magenta","year":"2017","journal-title":"Circ. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.ajpath.2012.07.009","article-title":"MiR-200c Inhibits Melanoma Progression and Drug Resistance through down-Regulation of BMI-1","volume":"181","author":"Liu","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/gcc.22422","article-title":"Epigenetic Silencing of MiR-200c in Breast Cancer Is Associated with Aggressiveness and Is Modulated by ZEB1","volume":"56","author":"Damiano","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1038\/cdd.2011.42","article-title":"MiR-200c Is Upregulated by Oxidative Stress and Induces Endothelial Cell Apoptosis and Senescence via ZEB1 Inhibition","volume":"18","author":"Magenta","year":"2011","journal-title":"Cell Death Differ."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1089\/ars.2016.6643","article-title":"Oxidative Stress-Induced MiR-200c Disrupts the Regulatory Loop among SIRT1, FOXO1, and ENOS","volume":"27","author":"Carlomosti","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35040556","article-title":"Conservation of the Sequence and Temporal Expression of Let-7 Heterochronic Regulatory RNA","volume":"408","author":"Pasquinelli","year":"2000","journal-title":"Nature"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tcb.2008.07.007","article-title":"The Let-7 Family of MicroRNAs","volume":"18","author":"Roush","year":"2008","journal-title":"Trends Cell Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ncrna.2016.10.003","article-title":"Role of Let-7 Family MicroRNA in Breast Cancer","volume":"1","author":"Thammaiah","year":"2016","journal-title":"Non-Coding RNA Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/cr.2008.45","article-title":"MicroRNA Let-7b Targets Important Cell Cycle Molecules in Malignant Melanoma Cells and Interferes with Anchorage-Independent Growth","volume":"18","author":"Schultz","year":"2008","journal-title":"Cell Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.2119\/molmed.2010.00225","article-title":"Let-7 MicroRNAs Induce Tamoxifen Sensitivity by Downregulation of Estrogen Receptor \u03b1 Signaling in Breast Cancer","volume":"17","author":"Zhao","year":"2011","journal-title":"Mol. Med."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Chen, D., Bao, C., Zhao, F., Yu, H., Zhong, G., Xu, L., and Yan, S. (2020). Exploring Specific MiRNA-MRNA Axes with Relationship to Taxanes-Resistance in Breast Cancer. Front. Oncol., 10.","DOI":"10.3389\/fonc.2020.01397"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.3892\/mmr.2016.5656","article-title":"Let-7 MiRNAs Sensitize Breast Cancer Stem Cells to Radiation-induced Repression through Inhibition of the Cyclin D1\/Akt1\/Wnt1 Signaling Pathway","volume":"14","author":"Sun","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1158\/1541-7786.MCR-16-0287-T","article-title":"Let-7 Status Is Crucial for PARP1 Expression in HER2-Overexpressing Breast Tumors","volume":"15","author":"Wielgos","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s11845-025-03923-6","article-title":"Let-7a MicroRNA Modulates Caspase-3-Dependent Apoptosis in Melanoma Cells Treated with Dabrafenib and Trametinib Combination","volume":"194","author":"Keser","year":"2025","journal-title":"Ir. J. Med. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/2326-6066.CIR-18-0331","article-title":"LIN28\/Let-7\/PD-L1 Pathway as a Target for Cancer Immunotherapy","volume":"7","author":"Chen","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e00056","DOI":"10.1002\/prp2.56","article-title":"Inhibition of Let-7 Micro RNA Attenuates Myocardial Remodeling and Improves Cardiac Function Postinfarction in Mice","volume":"2","author":"Tolonen","year":"2014","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"110709","DOI":"10.1016\/j.biopha.2020.110709","article-title":"MicroRNAs Associated to Anthracycline-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review and Pathway Analysis","volume":"131","author":"Pereira","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.febslet.2008.03.057","article-title":"Downregulation of CCND1 and CDK6 by MiR-34a Induces Cell Cycle Arrest","volume":"582","author":"Sun","year":"2008","journal-title":"FEBS Lett."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/cdd.2009.56","article-title":"The MiR-34 Family in Cancer and Apoptosis","volume":"17","author":"Hermeking","year":"2010","journal-title":"Cell Death Differ."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"872","DOI":"10.18632\/oncotarget.1825","article-title":"MiR-34: From Bench to Bedside","volume":"5","author":"Agostini","year":"2014","journal-title":"Oncotarget"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"106270","DOI":"10.18632\/oncotarget.22286","article-title":"MiR-34a Expression in Human Breast Cancer Is Associated with Drug Resistance","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Hua, C.-C., Liu, X.-M., Liang, L.-R., Wang, L.-F., and Zhong, J.-C. (2021). Targeting the MicroRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.784044"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/jcmm.12131","article-title":"MicroRNAs: Key Players of Taxane Resistance and Their Therapeutic Potential in Human Cancers","volume":"17","author":"Cui","year":"2013","journal-title":"J. Cell. Mol. Med."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1158\/1078-0432.CCR-25-1406","article-title":"BET Bromodomain Inhibition Reverses CDK4\/6 Inhibitor Resistance in Estrogen Receptor-Positive Breast Cancer via Induction of MiR-34a-5p","volume":"31","author":"Liu","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Tamas, T., Raduly, L., Berindan-Neagoe, I., Dinu, C., Botan, E., Bumbu, B., Tamas, A., Stoia, S., Leucuta, D.C., and Bran, S. (2023). The Role of MiRNA-221 and MiRNA-34a in Non-Melanoma Skin Cancer of the Head and Neck Region. Genes, 14.","DOI":"10.3390\/genes14020503"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/CIRCRESAHA.111.243592","article-title":"Repression of P66Shc Expression by SIRT1 Contributes to the Prevention of Hyperglycemia-Induced Endothelial Dysfunction","volume":"109","author":"Zhou","year":"2011","journal-title":"Circ. Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0968-0004(96)10033-5","article-title":"Not All Shc\u2019s Roads Lead to Ras","volume":"21","author":"Bonfini","year":"1996","journal-title":"Trends Biochem. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 Study of MRX34, a Liposomal MiR-34a Mimic, in Patients with Advanced Solid Tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_95","first-page":"539","article-title":"The Role of MiR-29b in Cancer: Regulation, Function, and Signaling","volume":"8","author":"Yan","year":"2015","journal-title":"OncoTargets Ther."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1038\/s41598-017-05727-w","article-title":"The MiR-29 Transcriptome in Endocrine-Sensitive and Resistant Breast Cancer Cells","volume":"7","author":"Muluhngwi","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12943-016-0554-y","article-title":"Systems Analysis Identifies MiR-29b Regulation of Invasiveness in Melanoma","volume":"15","author":"Andrews","year":"2016","journal-title":"Mol. Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Vera, O., Bok, I., Jasani, N., Nakamura, K., Xu, X., Mecozzi, N., Angarita, A., Wang, K., Tsai, K.Y., and Karreth, F.A. (2021). A MAPK\/MiR-29 Axis Suppresses Melanoma by Targeting MAFG and MYBL2. Cancers, 13.","DOI":"10.3390\/cancers13061408"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40959-025-00397-4","article-title":"Soluble Neprilysin Is Associated with Myocardial Damage and Systolic Dysfunction in an Animal Model of Doxorubicin-Induced Cardiotoxicity","volume":"12","author":"Sztechman","year":"2026","journal-title":"Cardio-Oncology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.canlet.2016.12.007","article-title":"Tamoxifen Differentially Regulates MiR-29b-1 and MiR-29a Expression Depending on Endocrine-Sensitivity in Breast Cancer Cells","volume":"388","author":"Muluhngwi","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Muluhngwi, P., and Klinge, C.M. (2021). Identification and Roles of MiR-29b-1-3p and MiR29a-3p-Regulated and Non-Regulated LncRNAs in Endocrine-Sensitive and Resistant Breast Cancer Cells. Cancers, 13.","DOI":"10.3390\/cancers13143530"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/s41419-020-02980-2","article-title":"C-Myc Regulates the Sensitivity of Breast Cancer Cells to Palbociclib via c-Myc\/MiR-29b-3p\/CDK6 Axis","volume":"11","author":"Ji","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e12764","DOI":"10.1111\/cpr.12764","article-title":"Aberrant Expression of MiR-29b-3p Influences Heart Development and Cardiomyocyte Proliferation by Targeting NOTCH2","volume":"53","author":"Yang","year":"2020","journal-title":"Cell Prolif."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1038\/s41467-017-01737-4","article-title":"Cardiac Myocyte MiR-29 Promotes Pathological Remodeling of the Heart by Activating Wnt Signaling","volume":"8","author":"Sassi","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacc.2013.09.041","article-title":"Circulating MiR-29a, among Other up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients with Hypertrophic Cardiomyopathy","volume":"63","author":"Roncarati","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Cha\u0142ubi\u0144ska-Fendler, J., Nowicka, Z., Dr\u00f3\u017cd\u017c, I., Graczyk, \u0141., Piotrowski, G., Tomasik, B., Spych, M., Fijuth, J., Papis-Ubych, A., and K\u0119dzierawski, P. (2023). Radiation-Induced Circulating MicroRNAs Linked to Echocardiography Parameters after Radiotherapy. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1150979"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"9623412","DOI":"10.1155\/2018\/9623412","article-title":"MiR-30 Family: A Promising Regulator in Development and Disease","volume":"2018","author":"Mao","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Jamshidi, M., Fagerholm, R., Muranen, T.A., Kaur, S., Potdar, S., Khan, S., Netti, E., Mpindi, J.-P., Yadav, B., and Kiiski, J.I. (2021). High MiR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment Outcome. Cancers, 13.","DOI":"10.3390\/cancers13122907"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"41309","DOI":"10.1038\/srep41309","article-title":"The Role of MiR-26a and MiR-30b in HER2+ Breast Cancer Trastuzumab Resistance and Regulation of the CCNE2 Gene","volume":"7","author":"Tormo","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10549-010-0940-x","article-title":"MicroRNA-30c Expression Level Is an Independent Predictor of Clinical Benefit of Endocrine Therapy in Advanced Estrogen Receptor Positive Breast Cancer","volume":"127","author":"Sieuwerts","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Nemours, S., Sol\u00e9, C., Goicoechea, I., Armesto, M., Arestin, M., Urruticoechea, A., Rezola, M., L\u00f3pez, I.\u00c1., Schaapveld, R., and Schultz, I. (2024). Use of Gain-of-Function Screening to Identify MiRNAs Involved in Paclitaxel Resistance in Triple-Negative Breast Cancer. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252413630"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/ced.12736","article-title":"MicroRNA Profiling for Early Detection of Nonmelanoma Skin Cancer","volume":"41","author":"Balci","year":"2016","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/CIRCRESAHA.108.182535","article-title":"MiR-133 and MiR-30 Regulate Connective Tissue Growth Factor: Implications for a Role of MicroRNAs in Myocardial Matrix Remodeling","volume":"104","author":"Duisters","year":"2009","journal-title":"Circ. Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"9883","DOI":"10.1038\/s41598-018-28118-1","article-title":"Circulating MiR-30a-5p as a Prognostic Biomarker of Left Ventricular Dysfunction after Acute Myocardial Infarction","volume":"8","author":"Maciejak","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Toury, L., Frankel, D., Airault, C., Magdinier, F., Roll, P., and Kaspi, E. (2022). MiR-140-5p and MiR-140-3p: Key Actors in Aging-Related Diseases?. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911439"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/jcp.29122","article-title":"MiR-140-5p Is Negatively Correlated with Proliferation, Invasion, and Tumorigenesis in Malignant Melanoma by Targeting SOX4 via the Wnt\/\u03b2-Catenin and NF-\u039aB Cascades","volume":"235","author":"Zhao","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2478\/acph-2022-0039","article-title":"MicroRNA-140-5p Inhibits Cellular Proliferation, Migration and Invasion by Downregulating AKT\/STAT3\/NF-\u039aB Pathway in Breast Carcinoma Cells","volume":"72","author":"Hou","year":"2022","journal-title":"Acta Pharm."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Di Cosimo, S., Appierto, V., Pizzamiglio, S., Silvestri, M., Baselga, J., Piccart, M., Huober, J., Izquierdo, M., de la Pena, L., and Hilbers, F.S. (2020). Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21041386"},{"key":"ref_119","first-page":"839","article-title":"MicroRNA-140-5p Aggravates Hypertension and Oxidative Stress of Atherosclerosis via Targeting Nrf2 and Sirt2","volume":"43","author":"Liu","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"840","DOI":"10.4070\/kcj.2025.0008","article-title":"MiR-140-5p Ameliorates Atrial Fibrillation in Cardiomyocytes by Targeting the Water Channel Protein Aquaporin 4","volume":"55","author":"Park","year":"2025","journal-title":"Korean Circ. J."},{"key":"ref_121","first-page":"6311","article-title":"MiR-140-5p Targets BCL2L1 to Promote Cardiomyocyte Apoptosis","volume":"24","author":"Sun","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2174\/0115665240327822241104060015","article-title":"MiR-144\/451: A Regulatory Role in Inflammation","volume":"25","author":"Zhu","year":"2025","journal-title":"Curr. Mol. Med."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Kooshkaki, O., Rezaei, Z., Rahmati, M., Vahedi, P., Derakhshani, A., Brunetti, O., Baghbanzadeh, A., Mansoori, B., Silvestris, N., and Baradaran, B. (2020). MiR-144: A New Possible Therapeutic Target and Diagnostic\/Prognostic Tool in Cancers. Int. J. Mol. Sci., 21.","DOI":"10.20944\/preprints202003.0034.v1"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.2147\/OTT.S103650","article-title":"MiR-144 Functions as a Tumor Suppressor in Breast Cancer through Inhibiting ZEB1\/2-Mediated Epithelial Mesenchymal Transition Process","volume":"9","author":"Pan","year":"2016","journal-title":"OncoTargets Ther."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00277-019-03737-4","article-title":"MiR-144 Regulates Oxidative Stress Tolerance of Thalassemic Erythroid Cell via Targeting NRF2","volume":"98","author":"Srinoun","year":"2019","journal-title":"Ann. Hematol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcancer.2025.06.005","article-title":"The Converging Roles of MicroRNAs and Lipid Metabolism in Atherosclerotic Cardiovascular Disease and Cancer","volume":"114","author":"Vladimirov","year":"2025","journal-title":"Semin. Cancer Biol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3892\/mmr.2025.13619","article-title":"MicroRNAs: Novel Clinical Biomarkers for Cancer Radiotherapy (Review)","volume":"32","author":"Park","year":"2025","journal-title":"Mol. Med. Rep."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"59287","DOI":"10.18632\/oncotarget.11040","article-title":"MiR-146a-5p Inhibits Cell Proliferation and Cell Cycle Progression in NSCLC Cell Lines by Targeting CCND1 and CCND2","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s12032-011-9862-7","article-title":"MicroRNA-146a Is down-Regulated in Gastric Cancer and Regulates Cell Proliferation and Apoptosis","volume":"29","author":"Hou","year":"2012","journal-title":"Med. Oncol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1038\/onc.2008.171","article-title":"Expression of MicroRNA-146 Suppresses NF-KappaB Activity with Reduction of Metastatic Potential in Breast Cancer Cells","volume":"27","author":"Bhaumik","year":"2008","journal-title":"Oncogene"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1158\/0008-5472.CAN-09-2792","article-title":"MiR-146a Suppresses Invasion of Pancreatic Cancer Cells","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e01460","DOI":"10.7554\/eLife.01460","article-title":"MiR-146a Promotes the Initiation and Progression of Melanoma by Activating Notch Signaling","volume":"3","author":"Forloni","year":"2014","journal-title":"eLife"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1084\/jem.20101823","article-title":"MiR-146a Is a Significant Brake on Autoimmunity, Myeloproliferation, and Cancer in Mice","volume":"208","author":"Boldin","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/CIRCRESAHA.115.306300","article-title":"MicroRNA Regulation of Atherosclerosis","volume":"118","author":"Feinberg","year":"2016","journal-title":"Circ. Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e70121","DOI":"10.1111\/jcmm.70121","article-title":"Unveiling the Therapeutic Potential of MiR-146a: Targeting Innate Inflammation in Atherosclerosis","volume":"28","author":"Ardinal","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12951-024-02631-0","article-title":"Targeting Delivery of MiR-146a via IMTP Modified Milk Exosomes Exerted Cardioprotective Effects by Inhibiting NF-\u039aB Signaling Pathway after Myocardial Ischemia-Reperfusion Injury","volume":"22","author":"Meng","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1007\/s11033-022-07253-z","article-title":"MiR-146a Contributes to Atherosclerotic Plaque Stability by Regulating the Expression of TRAF6 and IRAK-1","volume":"49","author":"Chu","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Wang, H., Tan, Z., Hu, H., Liu, H., Wu, T., Zheng, C., Wang, X., Luo, Z., Wang, J., and Liu, S. (2019). MicroRNA-21 Promotes Breast Cancer Proliferation and Metastasis by Targeting LZTFL1. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5951-3"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Martin del Campo, S.E., Latchana, N., Levine, K.M., Grignol, V.P., Fairchild, E.T., Jaime-Ramirez, A.C., Dao, T.-V., Karpa, V.I., Carson, M., and Ganju, A. (2015). MiR-21 Enhances Melanoma Invasiveness via Inhibition of Tissue Inhibitor of Metalloproteinases 3 Expression: In Vivo Effects of MiR-21 Inhibitor. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0115919"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"22262","DOI":"10.18632\/oncotarget.14763","article-title":"MicroRNAs in Melanoma Development and Resistance to Target Therapy","volume":"8","author":"Fattore","year":"2017","journal-title":"Oncotarget"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12943-026-02603-y","article-title":"MiRNA-Driven Cancer Cell Plasticity, Tolerance and Therapy Resistance: Lessons from Melanoma","volume":"25","author":"Ortolano","year":"2026","journal-title":"Mol. Cancer"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Si, Z., Zhong, Y., Lao, S., Wu, Y., Zhong, G., and Zeng, W. (2022). The Role of MiRNAs in the Resistance of Anthracyclines in Breast Cancer: A Systematic Review. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.899145"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"19127","DOI":"10.1074\/jbc.M110.216887","article-title":"Up-Regulation of MiR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer","volume":"286","author":"Gong","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biopha.2015.11.005","article-title":"Silencing of MicroRNA-21 Confers the Sensitivity to Tamoxifen and Fulvestrant by Enhancing Autophagic Cell Death through Inhibition of the PI3K-AKT-MTOR Pathway in Breast Cancer Cells","volume":"77","author":"Yu","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/s41388-018-0178-3","article-title":"MiR-21 Depletion in Macrophages Promotes Tumoricidal Polarization and Enhances PD-1 Immunotherapy","volume":"37","author":"Xi","year":"2018","journal-title":"Oncogene"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 Contributes to Myocardial Disease by Stimulating MAP Kinase Signalling in Fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"29514","DOI":"10.1074\/jbc.M109.027896","article-title":"MicroRNA Expression Signature and the Role of MicroRNA-21 in the Early Phase of Acute Myocardial Infarction","volume":"284","author":"Dong","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4161\/rna.8.5.16154","article-title":"Regulation and Function of MiRNA-21 in Health and Disease","volume":"8","author":"Kumarswamy","year":"2011","journal-title":"RNA Biol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.3390\/ijms16036353","article-title":"The Role of Hypoxia-Induced MiR-210 in Cancer Progression","volume":"16","author":"Dang","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.4161\/cc.9.6.11006","article-title":"MicroRNA-210: A Unique and Pleiotropic Hypoxamir","volume":"9","author":"Chan","year":"2010","journal-title":"Cell Cycle"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.molmed.2010.03.004","article-title":"MiR-210\u2014Micromanager of the Hypoxia Pathway","volume":"16","author":"Huang","year":"2010","journal-title":"Trends Mol. Med."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Gorospe, M., Tominaga, K., Wu, X., F\u00e4hling, M., and Ivan, M. (2011). Post-Transcriptional Control of the Hypoxic Response by RNA-Binding Proteins and MicroRNAs. Front. Mol. Neurosci., 4.","DOI":"10.3389\/fnmol.2011.00007"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1172\/JCI45105","article-title":"The Cellular Response to Hypoxia: Tuning the System with MicroRNAs","volume":"120","author":"Loscalzo","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1756-9966-33-50","article-title":"Multiple Functions of Hypoxia-Regulated MiR-210 in Cancer","volume":"33","author":"Qin","year":"2014","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/abbs\/gmt141","article-title":"Emerging Roles of MiR-210 and Other Non-Coding RNAs in the Hypoxic Response","volume":"46","author":"Huang","year":"2014","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1158\/1078-0432.CCR-07-1755","article-title":"Hsa-MiR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer","volume":"14","author":"Camps","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.18632\/oncotarget.3142","article-title":"A Direct Plasma Assay of Circulating MicroRNA-210 of Hypoxia Can Identify Early Systemic Metastasis Recurrence in Melanoma Patients","volume":"6","author":"Ono","year":"2015","journal-title":"Oncotarget"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1089\/ars.2021.0200","article-title":"MiR-210 HypoxamiR in Angiogenesis and Diabetes","volume":"36","author":"Zaccagnini","year":"2022","journal-title":"Antioxid. Redox Signal."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"110903","DOI":"10.1016\/j.biopha.2020.110903","article-title":"MiR-1: A Comprehensive Review of Its Role in Normal Development and Diverse Disorders","volume":"132","author":"Safa","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijbiomac.2015.08.016","article-title":"Hsa-MiR-1 Suppresses Breast Cancer Development by down-Regulating K-Ras and Long Non-Coding RNA MALAT1","volume":"81","author":"Liu","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cell.2007.03.030","article-title":"Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking MiRNA-1-2","volume":"129","author":"Zhao","year":"2007","journal-title":"Cell"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nm1569","article-title":"The Muscle-Specific MicroRNA MiR-1 Regulates Cardiac Arrhythmogenic Potential by Targeting GJA1 and KCNJ2","volume":"13","author":"Yang","year":"2007","journal-title":"Nat. Med."},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Pellegrini, L., Sileno, S., D\u2019Agostino, M., Foglio, E., Florio, M.C., Guzzanti, V., Russo, M.A., Limana, F., and Magenta, A. (2020). MicroRNAs in Cancer Treatment-Induced Cardiotoxicity. Cancers, 12.","DOI":"10.3390\/cancers12030704"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Sadat-Ebrahimi, S.-R., Rezabakhsh, A., Aslanabadi, N., Asadi, M., Zafari, V., Shanebandi, D., Zarredar, H., Enamzadeh, E., Taghizadeh, H., and Badalzadeh, R. (2025). Correction: Novel Diagnostic Potential of MiR-1 in Patients with Acute Heart Failure. PLoS ONE, 20, Correction in PLoS ONE\u00a02025, 20, e0320341.","DOI":"10.1371\/journal.pone.0320341"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/cvr\/cvp232","article-title":"MicroRNA-1 Downregulation by Propranolol in a Rat Model of Myocardial Infarction: A New Mechanism for Ischaemic Cardioprotection","volume":"84","author":"Lu","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1177\/0963689719843806","article-title":"MicroRNA-133a and Myocardial Infarction","volume":"28","author":"Xiao","year":"2019","journal-title":"Cell Transplant."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1038\/jid.2008.452","article-title":"MiRNA Expression Profiling in Melanocytes and Melanoma Cell Lines Reveals MiRNAs Associated with Formation and Progression of Malignant Melanoma","volume":"129","author":"Mueller","year":"2009","journal-title":"J. Investig. Dermatol."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Wu, Z., Wang, C., Xiang, R., Liu, X., Ye, S., Yang, X., Zhang, G., Xu, X., Zhu, T., and Wu, Q. (2012). Loss of MiR-133a Expression Associated with Poor Survival of Breast Cancer and Restoration of MiR-133a Expression Inhibited Breast Cancer Cell Growth and Invasion. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-51"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1423-0127-18-22","article-title":"Role of MiR-1 and MiR-133a in Myocardial Ischemic Postconditioning","volume":"18","author":"He","year":"2011","journal-title":"J. Biomed. Sci."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1161\/CIRCGENETICS.110.958975","article-title":"Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients with Cardiovascular Disease Indicate Myocardial Damage","volume":"4","author":"Kuwabara","year":"2011","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/1479-5876-11-222","article-title":"Plasma MicroRNA-133a Is a New Marker for Both Acute Myocardial Infarction and Underlying Coronary Artery Stenosis","volume":"11","author":"Wang","year":"2013","journal-title":"J. Transl. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1373\/clinchem.2009.125310","article-title":"Plasma MiR-208 as a Biomarker of Myocardial Injury","volume":"55","author":"Ji","year":"2009","journal-title":"Clin. Chem."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Tanno, B., Novelli, F., Leonardi, S., Merla, C., Babini, G., Giardullo, P., Kadhim, M., Traynor, D., Medipally, D.K.R., and Meade, A.D. (2022). MiRNA-Mediated Fibrosis in the Out-of-Target Heart Following Partial-Body Irradiation. Cancers, 14.","DOI":"10.3390\/cancers14143463"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s11010-022-04515-z","article-title":"Upregulation LncRNA MEG3 Expression Suppresses Proliferation and Metastasis in Melanoma via MiR-208\/SOX4","volume":"478","author":"Yang","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"32944","DOI":"10.18632\/oncotarget.5079","article-title":"MiR-208a Stimulates the Cocktail of SOX2 and \u03b2-Catenin to Inhibit the Let-7 Induction of Self-Renewal Repression of Breast Cancer Stem Cells and Formed MiR208a\/Let-7 Feedback Loop via LIN28 and DICER1","volume":"6","author":"Sun","year":"2015","journal-title":"Oncotarget"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/jat.3044","article-title":"Plasma MiR-208 as a Useful Biomarker for Drug-Induced Cardiotoxicity in Rats","volume":"35","author":"Nishimura","year":"2015","journal-title":"J. Appl. Toxicol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3164\/jcbn.22-130","article-title":"TMEM189 as a Target Gene of MiR-499a-5p Regulates Breast Cancer Progression through the Ferroptosis Pathway","volume":"73","author":"Fan","year":"2023","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"2086564","DOI":"10.1155\/2018\/2086564","article-title":"LncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging MiR-499-5p","volume":"2018","author":"Long","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"135","DOI":"10.21037\/atm.2016.03.40","article-title":"Circulating MiR-499 as a Potential Biomarker for Acute Myocardial Infarction","volume":"4","author":"Xin","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/eurheartj\/ehq167","article-title":"Circulating MicroRNAs Are New and Sensitive Biomarkers of Myocardial Infarction","volume":"31","author":"Devanna","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_181","first-page":"6547","article-title":"MiR-126 Regulated Breast Cancer Cell Invasion by Targeting ADAM9","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"7600","DOI":"10.1111\/jcmm.15396","article-title":"MiR-126 Reduces Trastuzumab Resistance by Targeting PIK3R2 and Regulating AKT\/MTOR Pathway in Breast Cancer Cells","volume":"24","author":"Fu","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1016\/j.ejca.2013.07.145","article-title":"Increased Expression of MiR-126 and MiR-10a Predict Prolonged Relapse-Free Time of Primary Oestrogen Receptor-Positive Breast Cancer Following Tamoxifen Treatment","volume":"49","author":"Hoppe","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Andrikopoulou, A., Shalit, A., Zografos, E., Koutsoukos, K., Korakiti, A.-M., Liontos, M., Dimopoulos, M.-A., and Zagouri, F. (2021). MicroRNAs as Potential Predictors of Response to CDK4\/6 Inhibitor Treatment. Cancers, 13.","DOI":"10.3390\/cancers13164114"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s13046-019-1238-4","article-title":"MiR-126-3p down-Regulation Contributes to Dabrafenib Acquired Resistance in Melanoma by up-Regulating ADAM9 and VEGF-A","volume":"38","author":"Caporali","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ymthe.2023.11.021","article-title":"MiR126-Targeted-Nanoparticles Combined with PI3K\/AKT Inhibitor as a New Strategy to Overcome Melanoma Resistance","volume":"32","author":"Arasi","year":"2024","journal-title":"Mol. Ther."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"117953","DOI":"10.1016\/j.biopha.2025.117953","article-title":"MicroRNA-126: From Biology to Therapeutics","volume":"185","author":"Guo","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s12282-017-0776-x","article-title":"The Role of MiR-130a in Cancer","volume":"24","author":"Zhang","year":"2017","journal-title":"Breast Cancer"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.1158\/0008-5472.CAN-17-0530","article-title":"MiR-130a Deregulates PTEN and Stimulates Tumor Growth","volume":"77","author":"Wei","year":"2017","journal-title":"Cancer Res."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"41942","DOI":"10.1038\/srep41942","article-title":"MicroRNA-130b Targets PTEN to Mediate Drug Resistance and Proliferation of Breast Cancer Cells via the PI3K\/Akt Signaling Pathway","volume":"7","author":"Miao","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1038\/srep05026","article-title":"Peripheral Blood MiRNAs as a Biomarker for Chronic Cardiovascular Diseases","volume":"4","author":"Jiang","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"e006763","DOI":"10.1161\/JAHA.117.006763","article-title":"MicroRNA-130a, a Potential Antifibrotic Target in Cardiac Fibrosis","volume":"6","author":"Li","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","article-title":"Tolerance, Danger, and the Extended Family","volume":"12","author":"Matzinger","year":"1994","journal-title":"Annu. Rev. Immunol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0306164","article-title":"DAMPs, PAMPs and Alarmins: All We Need to Know about Danger","volume":"81","author":"Bianchi","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s43556-025-00305-3","article-title":"Damage-Associated Molecular Patterns (DAMPs) in Diseases: Implications for Therapy","volume":"6","author":"Lin","year":"2025","journal-title":"Mol. Biomed."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41577-024-01027-3","article-title":"DAMP Sensing and Sterile Inflammation: Intracellular, Intercellular and Inter-Organ Pathways","volume":"24","author":"Huang","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1189\/jlb.1008585","article-title":"HMGB1 Loves Company","volume":"86","author":"Bianchi","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.gene.2006.08.034","article-title":"The Evolution of High Mobility Group Box (HMGB) Chromatin Proteins in Multicellular Animals","volume":"387","author":"Sessa","year":"2007","journal-title":"Gene"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.4110\/in.2018.18.e27","article-title":"Damage-Associated Molecular Patterns in Inflammatory Diseases","volume":"18","author":"Roh","year":"2018","journal-title":"Immune Netw."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.immuni.2024.03.002","article-title":"DAMPs and DAMP-Sensing Receptors in Inflammation and Diseases","volume":"57","author":"Ma","year":"2024","journal-title":"Immunity"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/s41392-025-02264-1","article-title":"Pattern Recognition Receptors: Function, Regulation and Therapeutic Potential","volume":"10","author":"Chen","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"30393","DOI":"10.1074\/jbc.M111.266528","article-title":"Toll-like Receptor 4 (TLR4) Is Essential for Hsp70-like Protein 1 (HSP70L1) to Activate Dendritic Cells and Induce Th1 Response","volume":"286","author":"Fang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI200114002","article-title":"The Multiligand Receptor RAGE as a Progression Factor Amplifying Immune and Inflammatory Responses","volume":"108","author":"Schmidt","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1016\/j.molcel.2025.09.007","article-title":"DAMPs in the Immunogenicity of Cell Death","volume":"85","author":"Chen","year":"2025","journal-title":"Mol. Cell"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.abb.2010.11.011","article-title":"The Release of High Mobility Group Box 1 in Apoptosis Is Triggered by Nucleosomal DNA Fragmentation","volume":"506","author":"Yamada","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"e1370","DOI":"10.1038\/cddis.2014.337","article-title":"Release and Activity of Histone in Diseases","volume":"5","author":"Chen","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nature09413","article-title":"Pannexin 1 Channels Mediate \u201cfind-Me\u201d Signal Release and Membrane Permeability during Apoptosis","volume":"467","author":"Chekeni","year":"2010","journal-title":"Nature"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.yexcr.2008.12.014","article-title":"The Content of DNA and RNA in Microparticles Released by Jurkat and HL-60 Cells Undergoing in Vitro Apoptosis","volume":"315","author":"Reich","year":"2009","journal-title":"Exp. Cell Res."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nrm732","article-title":"Secretory Lysosomes","volume":"3","author":"Blott","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"eaau6877","DOI":"10.1126\/science.aau6977","article-title":"The Biology, Function, and Biomedical Applications of Exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"Zapletal, E., Vasiljevic, T., Busson, P., and Matijevic Glavan, T. (2023). Dialog beyond the Grave: Necrosis in the Tumor Microenvironment and Its Contribution to Tumor Growth. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24065278"},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/1878-0261.12851","article-title":"Targeting Immunogenic Cell Death in Cancer","volume":"14","author":"Ahmed","year":"2020","journal-title":"Mol. Oncol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.toxlet.2018.04.034","article-title":"HMGB1 Contributes to Adriamycin-Induced Cardiotoxicity via up-Regulating Autophagy","volume":"292","author":"Luo","year":"2018","journal-title":"Toxicol. Lett."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Zhang, H., Wang, Z., Liu, Z., Du, K., and Lu, X. (2021). Protective Effects of Dexazoxane on Rat Ferroptosis in Doxorubicin-Induced Cardiomyopathy Through Regulating HMGB1. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.685434"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00018-024-05169-4","article-title":"Neutrophil Extracellular Traps Mediate Cardiomyocyte Ferroptosis via the Hippo-Yap Pathway to Exacerbate Doxorubicin-Induced Cardiotoxicity","volume":"81","author":"Zhao","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_216","doi-asserted-by":"crossref","unstructured":"B\u00f6rzsei, D., Nagy, A., Kiss, V., Vir\u00e1g, Z., Kis, G., Alm\u00e1si, N., T\u00f6r\u00f6k, S., Veszelka, M., Varga, C., and Szab\u00f3, R. (2025). Targeting Inflammation: Cytosporone B Modulates Imatinib-Driven Biochemical Alterations in Rat Heart. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262010018"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"6357","DOI":"10.2147\/JIR.S384279","article-title":"The Effect of PD-1 Inhibitor Combined with Irradiation on HMGB1-Associated Inflammatory Cytokines and Myocardial Injury","volume":"15","author":"Bai","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10495-025-02215-9","article-title":"HMGB1 Blockade Attenuates Cardiac Injury Induced by Radiotherapy Combined with PD-1 Inhibitor While Maintaining the Anti-Tumor Efficacy","volume":"31","author":"Liu","year":"2026","journal-title":"Apoptosis"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yjmcc.2023.11.007","article-title":"Targeting Heat Shock Protein 47 Alleviated Doxorubicin-Induced Cardiotoxicity and Remodeling in Mice through Suppression of the NLRP3 Inflammasome","volume":"186","author":"Shi","year":"2024","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0022-2828(03)00229-3","article-title":"Hsp10 and Hsp60 Modulate Bcl-2 Family and Mitochondria Apoptosis Signaling Induced by Doxorubicin in Cardiac Muscle Cells","volume":"35","author":"Shan","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_221","first-page":"1888","article-title":"Heat Shock Protein 90 Relieves Heat Stress Damage of Myocardial Cells by Regulating Akt and PKM2 Signaling In Vivo","volume":"45","author":"Zhang","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1158\/0008-5472.CAN-06-3721","article-title":"Heat Shock Protein 90 and ErbB2 in the Cardiac Response to Doxorubicin Injury","volume":"67","author":"Gabrielson","year":"2007","journal-title":"Cancer Res."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCRESAHA.108.182832","article-title":"Heat Shock Protein 20 Interacting with Phosphorylated Akt Reduces Doxorubicin-Triggered Oxidative Stress and Cardiotoxicity","volume":"103","author":"Fan","year":"2008","journal-title":"Circ. Res."},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Pei, X.M., Tam, B.T., Sin, T.K., Wang, F.F., Yung, B.Y., Chan, L.W., Wong, C.S., Ying, M., Lai, C.W., and Siu, P.M. (2016). S100A8 and S100A9 Are Associated with Doxorubicin-Induced Cardiotoxicity in the Heart of Diabetic Mice. Front. Physiol., 7.","DOI":"10.3389\/fphys.2016.00334"},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Alanazi, A.M., Fadda, L., Alhusaini, A., Ahmad, R., Hasan, I.H., and Mahmoud, A.M. (2020). Liposomal Resveratrol and\/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats. Antioxidants, 9.","DOI":"10.3390\/antiox9020159"},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Chen, C., Zheng, H., Wang, Y., Tong, Y., Zhang, H., Xie, S., Ma, X., Jiang, M., Gong, Z., and Yan, T. (2024). Changes in SST2 and NT-ProBNP Levels Predict Early Cardiac Arrhythmia in Breast Cancer Patients Treated with Anthracycline-Containing Chemotherapies. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1477679"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"20220841","DOI":"10.1515\/biol-2022-0841","article-title":"IL-33\/Soluble ST2 Axis Is Associated with Radiation-Induced Cardiac Injury","volume":"19","author":"Yasen","year":"2024","journal-title":"Open Life Sci."},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Taverna, S., Tonacci, A., Ferraro, M., Cammarata, G., Cuttitta, G., Bucchieri, S., Pace, E., and Gangemi, S. (2022). High Mobility Group Box 1: Biological Functions and Relevance in Oxidative Stress Related Chronic Diseases. Cells, 11.","DOI":"10.3390\/cells11050849"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like Receptor 4\u2013Dependent Contribution of the Immune System to Anticancer Chemotherapy and Radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat. Med."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"29914","DOI":"10.1038\/srep29914","article-title":"Tumour Hypoxia Promotes Melanoma Growth and Metastasis via High Mobility Group Box-1 and M2-like Macrophages","volume":"6","author":"Huber","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Foglio, E., Pellegrini, L., Russo, M.A., and Limana, F. (2022). HMGB1-Mediated Activation of the Inflammatory-Reparative Response Following Myocardial Infarction. Cells, 11.","DOI":"10.3390\/cells11020216"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/FJC.0000000000000003","article-title":"The Immune System and the Remodeling Infarcted Heart: Cell Biological Insights and Therapeutic Opportunities","volume":"63","author":"Frangogiannis","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1084\/jem.20120189","article-title":"Mutually Exclusive Redox Forms of HMGB1 Promote Cell Recruitment or Proinflammatory Cytokine Release","volume":"209","author":"Venereau","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s10557-024-07574-0","article-title":"A Comprehensive Overview on Chemotherapy-Induced Cardiotoxicity: Insights into the Underlying Inflammatory and Oxidative Mechanisms","volume":"39","author":"Nagy","year":"2025","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1007\/s00204-016-1759-y","article-title":"Pathways of Cardiac Toxicity: Comparison between Chemotherapeutic Drugs Doxorubicin and Mitoxantrone","volume":"90","author":"Damiani","year":"2016","journal-title":"Arch. Toxicol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/s43018-025-00988-1","article-title":"Cardiomyocyte-Localized CCDC25 Senses NET DNA to Promote Doxorubicin Cardiotoxicity by Activating Autophagic Flux","volume":"6","author":"Nie","year":"2025","journal-title":"Nat. Cancer"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJMra1100265","article-title":"Cardiovascular Toxic Effects of Targeted Cancer Therapies","volume":"375","author":"Moslehi","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"D\u00edaz-Gavela, A.A., Figueiras-Graillet, L., Luis, \u00c1.M., Salas Segura, J., Ci\u00e9rvide, R., Del Cerro Pe\u00f1alver, E., Cou\u00f1ago, F., Arenas, M., and L\u00f3pez-Fern\u00e1ndez, T. (2021). Breast Radiotherapy-Related Cardiotoxicity. When, How, Why. Risk Prevention and Control Strategies. Cancers, 13.","DOI":"10.3390\/cancers13071712"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0735-1097(03)00759-9","article-title":"Asymptomatic Cardiac Disease Following Mediastinal Irradiation","volume":"42","author":"Heidenreich","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7861\/clinmed.2021-0600","article-title":"Radiation-Induced Coronary Artery Disease: A Difficult Clinical Conundrum","volume":"22","author":"Kirresh","year":"2022","journal-title":"Clin. Med."},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"Sridharan, V., Krager, K.J., Pawar, S.A., Bansal, S., Li, Y., Cheema, A.K., and Boerma, M. (2023). Effects of Whole and Partial Heart Irradiation on Collagen, Mast Cells, and Toll-like Receptor 4 in the Mouse Heart. Cancers, 15.","DOI":"10.3390\/cancers15020406"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.canlet.2015.03.031","article-title":"Radiation Takes Its Toll","volume":"368","author":"Ratikan","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"11942","DOI":"10.1073\/pnas.1003893107","article-title":"A Critical Cysteine Is Required for HMGB1 Binding to Toll-like Receptor 4 and Activation of Macrophage Cytokine Release","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrclinonc.2016.211","article-title":"Radiotherapy and Immunotherapy: A Beneficial Liaison?","volume":"14","author":"Weichselbaum","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jtho.2017.12.002","article-title":"PD-1 Modulates Radiation-Induced Cardiac Toxicity through Cytotoxic T Lymphocytes","volume":"13","author":"Du","year":"2018","journal-title":"J. Thorac. Oncol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/ncb814","article-title":"Nucleophosmin Regulates the Stability and Transcriptional Activity of P53","volume":"4","author":"Colombo","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0092-8674(89)90241-9","article-title":"Major Nucleolar Proteins Shuttle between Nucleus and Cytoplasm","volume":"56","author":"Borer","year":"1989","journal-title":"Cell"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1021\/bi9627931","article-title":"Nucleolar Protein B23 Stimulates Nuclear Import of the HIV-1 Rev Protein and NLS-Conjugated Albumin","volume":"36","author":"Szebeni","year":"1997","journal-title":"Biochemistry"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1110\/ps.8.4.905","article-title":"Nucleolar Protein B23 Has Molecular Chaperone Activities","volume":"8","author":"Szebeni","year":"1999","journal-title":"Protein Sci."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0014-5793(01)02939-8","article-title":"Function of Nucleophosmin\/B23, a Nucleolar Acidic Protein, as a Histone Chaperone","volume":"506","author":"Okuwaki","year":"2001","journal-title":"FEBS Lett."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"16536","DOI":"10.1074\/jbc.M601386200","article-title":"Nucleophosmin Regulates Cell Cycle Progression and Stress Response in Hematopoietic Stem\/Progenitor Cells","volume":"281","author":"Li","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"16409","DOI":"10.1074\/jbc.M109.005736","article-title":"Nucleophosmin Blocks Mitochondrial Localization of P53 and Apoptosis","volume":"284","author":"Dhar","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_253","first-page":"3707","article-title":"Efficient DNA Binding of NF-\u039aB Requires the Chaperone-like Function of NPM1","volume":"45","author":"Lin","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_254","doi-asserted-by":"crossref","unstructured":"Di Carlo, A., Beji, S., Palmerio, S., Picozza, M., D\u2019Agostino, M., Petrozza, V., Melchionna, R., Germani, A., Magenta, A., and De Falco, E. (2021). The Nucleolar Protein Nucleophosmin Is Physiologically Secreted by Endothelial Cells in Response to Stress Exerting Proangiogenic Activity Both In Vitro and In Vivo. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073672"},{"key":"ref_255","doi-asserted-by":"crossref","unstructured":"Sharma, N., and Liesveld, J.L. (2023). NPM 1 Mutations in AML\u2014The Landscape in 2023. Cancers, 15.","DOI":"10.3390\/cancers15041177"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/CMAR.S191176","article-title":"Knockdown of Nucleophosmin 1 Suppresses Proliferation of Triple-Negative Breast Cancer Cells through Activating CDH1\/Skp2\/P27kip1 Pathway","volume":"11","author":"Zeng","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4103\/0377-4929.85079","article-title":"The Enigmatic Role of Nucleophosmin in Malignant Melanoma: Does It Have an Effect?","volume":"54","author":"Calli","year":"2011","journal-title":"Indian J. Pathol. Microbiol."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrc1885","article-title":"Nucleophosmin and Cancer","volume":"6","author":"Grisendi","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1189\/jlb.1008644","article-title":"Nucleophosmin May Act as an Alarmin: Implications for Severe Sepsis","volume":"86","author":"Nawa","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"e000062","DOI":"10.1161\/JAHA.113.000062","article-title":"Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Observational Studies","volume":"2","author":"Armstrong","year":"2013","journal-title":"J. Am. Heart Assoc."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2013.06.053","article-title":"Meta-Analysis of Psoriasis, Cardiovascular Disease, and Associated Risk Factors","volume":"69","author":"Miller","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2230.2010.03893.x","article-title":"Atherosclerosis as a Systemic Feature of Psoriasis","volume":"36","author":"Alexandroff","year":"2011","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_263","doi-asserted-by":"crossref","unstructured":"D\u2019Agostino, M., Beji, S., Sileno, S., Lulli, D., Mercurio, L., Madonna, S., Cirielli, C., Pallotta, S., Albanesi, C., and Capogrossi, M.C. (2022). Extracellular Nucleophosmin Is Increased in Psoriasis and Correlates with the Determinants of Cardiovascular Diseases. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.867813"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/bjd\/ljag152","article-title":"Nerve Growth Factor Receptor P75NTR Interacts with Toll-like Receptor 4 and the Alarmins High Mobility Group Box 1 and Nucleophosmin: A Novel Inflammatory Mechanism in Psoriasis","volume":"195","author":"Sileno","year":"2026","journal-title":"Br. J. Dermatol."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"31332","DOI":"10.1074\/jbc.M103217200","article-title":"Endocytosed HSP60s Use Toll-like Receptor 2 (TLR2) and TLR4 to Activate the Toll\/Interleukin-1 Receptor Signaling Pathway in Innate Immune Cells","volume":"276","author":"Vabulas","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_266","doi-asserted-by":"crossref","unstructured":"Hou, Q., Chen, S., An, Q., Li, B., Fu, Y., and Luo, Y. (2021). Extracellular Hsp90\u03b1 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147747"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s10495-019-01577-1","article-title":"Inhibitors of HSP90 in Melanoma","volume":"25","author":"Hartman","year":"2020","journal-title":"Apoptosis"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00008390-200304000-00006","article-title":"Heat Shock Protein 70 Membrane Expression and Melanoma-Associated Marker Phenotype in Primary and Metastatic Melanoma","volume":"13","author":"Farkas","year":"2003","journal-title":"Melanoma Res."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1379\/1466-1268(2003)008<0249:OOHIAH>2.0.CO;2","article-title":"Overexpression of Hsp27 in a Human Melanoma Cell Line: Regulation of E-Cadherin, MUC18\/MCAM, and Plasminogen Activator (PA) System","volume":"8","author":"Aldrian","year":"2003","journal-title":"Cell Stress Chaperones"},{"key":"ref_270","doi-asserted-by":"crossref","unstructured":"Patnaik, S., Nathan, S., Kar, B., Gregoric, I.D., and Li, Y.-P. (2023). The Role of Extracellular Heat Shock Proteins in Cardiovascular Diseases. Biomedicines, 11.","DOI":"10.3390\/biomedicines11061557"},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1161\/01.ATV.0000029720.59649.50","article-title":"Role of Heat Shock Proteins in Atherosclerosis","volume":"22","author":"Xu","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1161\/01.CIR.103.8.1071","article-title":"Antibodies to Human Heat-Shock Protein 60 Are Associated with the Presence and Severity of Coronary Artery Disease: Evidence for an Autoimmune Component of Atherogenesis","volume":"103","author":"Zhu","year":"2001","journal-title":"Circulation"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"6678457","DOI":"10.1155\/2021\/6678457","article-title":"Heat Shock Proteins in Oxidative Stress and Ischemia\/Reperfusion Injury and Benefits from Physical Exercises: A Review to the Current Knowledge","volume":"2021","author":"Szyller","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1164\/rccm.201708-1751OC","article-title":"Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension","volume":"198","author":"Boucherat","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1189\/jlb.0306170","article-title":"S100 Proteins Expressed in Phagocytes: A Novel Group of Damage-Associated Molecular Pattern Molecules","volume":"81","author":"Foell","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/cmi.2016.34","article-title":"HMGB1, IL-1\u03b1, IL-33 and S100 Proteins: Dual-Function Alarmins","volume":"14","author":"Bertheloot","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"ref_277","first-page":"F65","article-title":"RAGE and S100 Protein Transcription Levels Are Highly Variable in Human Melanoma Tumors and Cells","volume":"28","author":"Leclerc","year":"2009","journal-title":"Gen. Physiol. Biophys."},{"key":"ref_278","doi-asserted-by":"crossref","unstructured":"Wong, T., Kang, R., and Yun, K. (2025). The Multi-Faceted Immune Modulatory Role of S100A4 in Cancer and Chronic Inflammatory Disease. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1525567"},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1158\/0008-5472.CAN-14-2161","article-title":"RAGE Mediates S100A7-Induced Breast Cancer Growth and Metastasis by Modulating the Tumor Microenvironment","volume":"75","author":"Nasser","year":"2015","journal-title":"Cancer Res."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrc3893","article-title":"S100 Proteins in Cancer","volume":"15","author":"Bresnick","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s10020-023-00662-1","article-title":"S100 Proteins in Cardiovascular Diseases","volume":"29","author":"Zhou","year":"2023","journal-title":"Mol. Med."},{"key":"ref_282","doi-asserted-by":"crossref","unstructured":"Wang, S., Song, R., Wang, Z., Jing, Z., Wang, S., and Ma, J. (2018). S100A8\/A9 in Inflammation. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01298"},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.resuscitation.2020.08.010","article-title":"Protein S100B as a Reliable Tool for Early Prognostication after Cardiac Arrest","volume":"156","author":"Deye","year":"2020","journal-title":"Resuscitation"},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10741-021-10116-7","article-title":"Social and Environmental Risks as Contributors to the Clinical Course of Heart Failure","volume":"27","author":"Narita","year":"2022","journal-title":"Heart Fail. Rev."},{"key":"ref_285","first-page":"2167","article-title":"Roles of IL-33 in the Pathogenesis of Cardiac Disorders","volume":"248","author":"Jiang","year":"2023","journal-title":"Exp. Biol. Med."},{"key":"ref_286","doi-asserted-by":"crossref","unstructured":"Guo, H., Bossila, E.A., Ma, X., Zhao, C., and Zhao, Y. (2022). Dual Immune Regulatory Roles of Interleukin-33 in Pathological Conditions. Cells, 11.","DOI":"10.3390\/cells11203237"},{"key":"ref_287","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coi.2014.09.004","article-title":"IL-33: An Alarmin Cytokine with Crucial Roles in Innate Immunity, Inflammation and Allergy","volume":"31","author":"Cayrol","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"ref_288","doi-asserted-by":"crossref","unstructured":"Larsen, K.M., Minaya, M.K., Vaish, V., and Pe\u00f1a, M.M.O. (2018). The Role of IL-33\/ST2 Pathway in Tumorigenesis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092676"},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/ijc.28481","article-title":"Interleukin-33\/ST2 Axis Promotes Breast Cancer Growth and Metastases by Facilitating Intratumoral Accumulation of Immunosuppressive and Innate Lymphoid Cells","volume":"134","author":"Jovanovic","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yjmcc.2013.03.020","article-title":"Components of the Interleukin-33\/ST2 System Are Differentially Expressed and Regulated in Human Cardiac Cells and in Cells of the Cardiac Vasculature","volume":"60","author":"Demyanets","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_291","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.molmed.2012.05.005","article-title":"Inflammation in Viral Myocarditis: Friend or Foe?","volume":"18","author":"Corsten","year":"2012","journal-title":"Trends Mol. Med."},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"e388","DOI":"10.1038\/emm.2017.183","article-title":"IL-33 Promotes IL-10 Production in Macrophages: A Role for IL-33 in Macrophage Foam Cell Formation","volume":"49","author":"Zhang","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.4049\/jimmunol.1000520","article-title":"IL-33 Reduces Macrophage Foam Cell Formation","volume":"185","author":"McLaren","year":"2010","journal-title":"J. Immunol."},{"key":"ref_294","doi-asserted-by":"crossref","unstructured":"Demyanets, S., Speidl, W.S., Tentzeris, I., Jarai, R., Katsaros, K.M., Farhan, S., Krychtiuk, K.A., Wonnerth, A., Weiss, T.W., and Huber, K. (2014). Soluble ST2 and Interleukin-33 Levels in Coronary Artery Disease: Relation to Disease Activity and Adverse Outcome. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095055"},{"key":"ref_295","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1177\/15353702211034144","article-title":"Predictive Values of SST2 and IL-33 for Heart Failure in Patients with Acute Myocardial Infarction","volume":"246","author":"Xing","year":"2021","journal-title":"Exp. Biol. Med."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","article-title":"IL-33 and ST2 Comprise a Critical Biomechanically Induced and Cardioprotective Signaling System","volume":"117","author":"Sanada","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/cvr\/cvs015","article-title":"Reduction in IL-33 Expression Exaggerates Ischaemia\/Reperfusion-Induced Myocardial Injury in Mice with Diabetes Mellitus","volume":"94","author":"Rui","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1475-2840-10-101","article-title":"Toll\/Interleukin-1 Receptor Member ST2 Exhibits Higher Soluble Levels in Type 2 Diabetes, Especially When Accompanied with Left Ventricular Diastolic Dysfunction","volume":"10","author":"Fousteris","year":"2011","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.yjmcc.2019.04.009","article-title":"Yin-Yang 1 Transcription Factor Modulates ST2 Expression during Adverse Cardiac Remodeling Post-Myocardial Infarction","volume":"130","author":"Lax","year":"2019","journal-title":"J. Mol. Cell. Cardiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8329\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:29:42Z","timestamp":1790861382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":299,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27188329"],"URL":"https:\/\/doi.org\/10.3390\/ijms27188329","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]}}}